ClinConnect ClinConnect Logo
Search / Trial NCT00921271

The Application of Near Infrared Spectroscopy (NIRS) in the Detection of Lower Limb Compartment Syndrome

Launched by UNIVERSITY HOSPITAL BIRMINGHAM NHS FOUNDATION TRUST · Jun 15, 2009

Trial Information

Current as of June 13, 2025

Completed

Keywords

Compartment Syndrome

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with one or more of the following injuries:
  • tibial fracture
  • crush injury/soft tissue injury to lower limb without fracture
  • pelvic fracture
  • major vascular injury below the aortic bifurcation
  • 2 or more long bone fractures
  • Any patient sustaining a traumatic injury with a base deficit ≥ 6 mEq/L within 12 hours of Hospital admission.
  • Any patient receiving ≥ 6 units packed red blood cells within 12 hours of hospital admission.
  • Exclusion Criteria:
  • Age ≤ 16 years are excluded by design, as all pediatric cases are managed at Birmingham Childrens Hospital. There is no upper age limit.
  • Bilateral lower limb amputees.
  • Individuals who have received methylene blue within the previous week or during the study period.
  • Patient refusal to participated in the trial.
  • In the case of incapacitated patients, refusal by the patient's relatives/representatives, or where no representative can be identified.

About University Hospital Birmingham Nhs Foundation Trust

The University Hospital Birmingham NHS Foundation Trust is a leading academic health institution dedicated to providing exceptional patient care, advancing medical research, and enhancing education in the healthcare field. As a prominent sponsor of clinical trials, the Trust collaborates with a network of researchers and healthcare professionals to facilitate innovative studies aimed at improving treatment outcomes and patient experiences. With a strong commitment to ethical standards and patient safety, the Trust leverages its extensive resources and expertise to drive forward clinical research initiatives that contribute to the advancement of medical science and the health of the community.

Locations

Birmingham, West Midlands, United Kingdom

Patients applied

0 patients applied

Trial Officials

Tom Barker, MBChB, MRCS

Principal Investigator

University Hospitals Birmingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials